Applications and challenge of magnetic resonance imaging probes

CHU Chengchao; LIU Gang

doi:10.3981/j.issn.1000-7857.2018.22.007

PDF(2797 KB)

Science & Technology Review ›› 2018, Vol. 36 ›› Issue (22) : 87-95. DOI: 10.3981/j.issn.1000-7857.2018.22.007

Exclusive: Nanobiomedicine

Applications and challenge of magnetic resonance imaging probes

Author information -

Center for Molecular Image and Translational Medicine, Xiamen University, Xiamen 361102, China

Abstract

In recent years, apllications of magnetic nanomaterials in molecular imaging have attracted much attention. The superparamagnetic nanoparticle is the most popular magnetic nanoparticle due to its good T₂-weighted magnetic resonance imaging (MRI) contrast agent property. With the improvement of preparation and surface modification method, the superparamagnetic iron oxide particles (SPION) has been applied to imaging contrast, stem cell labeling and drug/gene delivery. This article reviews the combined applications of SPION in imaging contrast and MRI guided treatment. It also points out that many kinds of magnetic nanomaterials used for biomedical applications have low imaging contrast and specificity in vivo and have negative effecton living organism, which hinder the clinical application of SPION. Combined with the current public concerns and development of nanomedicine preparation methods, the preparation of SPION with good MRI contrast effect, high biocompatibility, disease area targeting and clinical conversion potential is a challenge to deal with in the new generation of magnetic nano-probes.

Key words

magnetic nanomaterials / magnetic resonance imaging / molecular probes / theranostics

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

CHU Chengchao, LIU Gang. Applications and challenge of magnetic resonance imaging probes[J]. Science & Technology Review, 2018, 36(22): 87-95 https://doi.org/10.3981/j.issn.1000-7857.2018.22.007

References

[1] Liu J N, Bu W B, Shi J L. Chemical design and synthesis of functionalized probes for imaging and treating tumor hypoxia[J]. Chemical Reviews, 2017, 117(9):6160-6224.
[2] England C G, Hernandez R, Eddine S B Z, et al. Molecular Imaging of pancreatic cancer with antibodies[J]. Molecular Pharmaceutics, 2016, 13(1):8-24.
[3] Prodi L, Rampazzo E, Rastrelli F, et al. Imaging agents based on lanthanide doped nanoparticles[J]. Chemical Society Review, 2015, 44(14):4922-4952.
[4] Yu E Y, Bishop M, Zheng B, et al. Magnetic particle imaging:A novel in vivo imaging platform for cancer detection[J]. Nano Letters, 2017, 17(3):1648-1654.
[5] Terreno E, Castelli D D, Viale A, et al. Challenges for molecular magnetic resonance imaging[J]. Chemical Reviews, 2010, 110(5):3019-3042.
[6] Cai W, Gao H Y, Chu C C, et al. Engineering phototheranostic nanoscale metal-organic frameworks for multimodal imagingguided cancer therapy[J]. ACS Applied Materials & Interfaces, 2017, 9(3):2040-2051.
[7] Prantner A M, Yin C, Kamat K, et al. Molecular imaging of mesothelin-expressing ovarian cancer with a human and mouse cross-reactive nanobody[J]. Molecular Pharmaceutics, 2018, 15(4):1403-1411.
[8] Bhatnagar S, Verma K D, Hu Y, et al. Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening[J]. Molecular Pharmaceutics, 2018, 15(5):1746-1754.
[9] Pati M L, Fanizza E, Hager S, et al. Quantum dot based luminescent nanoprobes for Sigma-2 receptor imaging[J]. Molecular Pharmaceutics, 2018, 15(2):458-471.
[10] Kunjachan S, Ehling J, Storm G, et al. Noninvasive imaging of nanomedicines and nanotheranostics:Principles, progress, and prospects[J]. Chemical Reviews, 2015, 115(19):10907-10937.
[11] He S S, Li C, Zhang Q F, et al. Tailoring platinum(IV) amphiphiles for self-targeting all-in-one assemblies as precise multimodal theranostic nanomedicine[J]. ACS Nano, 2018, 12(7):7272-7281.
[12] Sheng Z H, Hu D H, Zheng M B, et al. Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy[J]. ACS Nano, 2014, 8(12):12310-12322.
[13] Yu L X, Dong A J, Guo R W, et al. DOX/ICG coencapsulated liposome-coated thermosensitive nanogels for NIR-triggered simultaneous drug release and photothermal effect[J]. ACS Biomaterials Science & Engineering, 2018, 4(7):2424-2434.
[14] Fan W P, Yung B, Huang P, et al. Nanotechnology for multimodal synergistic cancer therapy[J]. Chemical Reviews, 2017, 117(22):13566-13638.
[15] Alivisatos P. The use of nanocrystals in biological detection[J]. Nature Biotechnology, 2004, 22:47-52.
[16] He C, Jiang S, Jin H, et al. Mitochondrial electron transport chain identified as a novel molecular target of SPIO nanoparticles mediated cancer-specific cytotoxicity[J]. Biomaterials, 2016, 83:102-114.
[17] Jana N R, Chen Y, Peng X. Size and shape-controlled magnetic (Cr, Mn, Fe, Co, Ni) oxide nanocrystals via a simple and general approach[J]. Chemistry of Materials, 2004, 16(20):3931-3935.
[18] Hao J J, Chen H L, Ren C L, et al. Synthesis of superparmagnetic Fe₃O₄ nanocrystals in reverse microemulsion at room temperature[J]. Materials Research Innovations, 2010, 14:324-326.
[19] Rockenberger J, Scher E C, Alivisatos A P. A new nonhydrolytic single-precursor approach to surfactant-capped nanocrystals of transition metal oxides[J]. Journal of the American Chemical Society, 1999, 121(49):11595-11596.
[20] Hyeon T, Lee S S, Park J, et al. Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process[J]. Journal of the American Chemical Society, 2001, 123(51):12798-12801.
[21] Lee N, Yoo D, Ling D, et al. Iron oxide based nanoparticles for multimodal imaging and magnetoresponsive therapy[J]. Chemical Reviews, 2015, 115(19):10637-10689.
[22] Huang K C, Ehrman S H. Synthesis of iron nanoparticles via chemical reduction with palladium ion seeds[J]. Langmuir, 2007, 23(3):1419-1426.
[23] Huang, Wang L, Lin R, et al. Casein-coated iron oxide nanoparticles for high MRI contrast enhancement and efficient cell targeting[J]. ACS Applied Materials & Interfaces, 2013, 5(11):4632-4639.
[24] Li Z, Chen H, Bao H B, et al. One-pot reaction to synthesize water-soluble magnetite nanocrystals[J]. Chemistry of Materials, 2004, 16(8):1391-1393.
[25] Zhao N, Gao M. Magnetic janus particles prepared by a flame synthetic approach:Synthesis, characterizations and properties[J]. Advanced Materials, 2009, 21(2):184-187.
[26] Jia Q, Zeng J, Qiao R, et al. Gelification:An effective measure for achieving differently sized biocompatible Fe₃O₄ nanocrystals through a single preparation recipe[J]. Journal of the American Chemical Society, 2011, 133(48):19512-19523.
[27] Liu G, Gao J H, Ai H, et al. Applications and potential toxicity of magnetic iron oxide nanoparticles[J]. Small, 2012, 9(9/10):1533-1545.
[28] Liu J, Wang L Q, Cao J B, et al. Functional investigations on embryonic stem cells labeled with clinically translatable iron oxide nanoparticles[J]. Nanoscale, 2014, 6(15):9025-9033.
[29] Liu G, Wang Z Y, Lu J, et al. Low molecular weight alkylpolycation wrapped magnetite nanoparticle clusters as MRI probes for stem cell labeling and in vivo imaging[J]. Biomaterials, 2011, 32(2):528-537.
[30] Wang L Y, Huang J, Chen H B, et al. Exerting enhanced permeability and retention effect driven delivery by ultrafine iron oxide nanoparticles with T₁-T₂ switchable magnetic resonance imaging contrast[J]. ACS Nano, 2017, 11(5):4582-4592.
[31] Lin S Y, Huang R Y, Liao W C, et al. Multifunctional PEGylated albumin/IR780/iron oxide nanocomplexes for cancer photothermal therapy and MR imaging[J]. Nanotheranostics, 2018, 2(2):106-116.
[32] Li D L, Tan J E, Tian Y, et al. Multifunctional superparamagnetic nanoparticles conjugated with fluorescein-labeled designed ankyrin repeat protein as an efficient HER2-targeted probe in breast cancer[J]. Biomaterials, 2017, 147:86-98.
[33] Lin L S, Cong Z X, Cao J B, et al. Multifunctional Fe₃O₄@Polydopamine core-shell nanocomposites for intracellular mRNA detection and imaging-guided photothermal therapy[J]. ACS Nano, 2014, 8(4):3876-3883.
[34] Wang J Q, Liu H, Liu Y, et al. Eumelanin-Fe₃O₄ hybrid nanoparticles for enhanced MR/PA imaging-assisted local photothermolysis[J]. Biomaterials Science, 2018, 6(3):586-595.
[35] Liu H, Chen X, Xue W, et al. Recombinant epidermal growth factor-like domain-1 from coagulation factor VⅡ functionalized iron oxide nanoparticles for targeted glioma magnetic resonance imaging[J]. International Journal of Nanomedicine, 2016, 11:5099-5108.
[36] Zhou Z, Tian R, Wang Z Y, et al. Artificial local magnetic field inhomogeneity enhances T₂ relaxivity[J]. Nature Communications, 2017, 8:15468.
[37] Zhao Z, Zhou Z, Bao J, et al. Octapod iron oxide nanoparticles as high-performance T₂ contrast agents for magnetic resonance imaging[J]. Nature Communications, 2013, 4:2266.
[38] Ma T, Hou Y, Zeng J, et al. Dual-ratiometric target-triggered fluorescent probe for simultaneous quantitative visualization of tumor microenvironment protease activity and pH in vivo[J]. Journal of the American Chemical Society, 2018, 140(1):211-218.
[39] Guthi J S, Yang S G, Huang G, et al. MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells[J]. Molecular Pharmaceutics, 2010, 7(1):32-40.
[40] Fan C H, Cheng Y H, Ting C Y, et al. Ultrasound/Magnetic targeting with SPIO-DOX-microbubble complex for imageguided drug delivery in brain tumors[J]. Theranostics, 2016, 6(10):1542-1556.
[41] Yang C X, Lin G, Zhu C Q, et al. Metalla-aromatic loaded magnetic nanoparticles for MRI/photoacoustic imaging-guided cancer phototherapy[J]. Journal of Materials Chemistry B, 2018, 6(17):2528-2535.
[42] Lin G, Zhang Y, Zhu C Q, et al. Photo-excitable hybrid nanocomposites for image-guided photo/TRAIL synergistic cancer therapy[J]. Biomaterials, 2018, 176:60-70.
[43] Liu G, Xie J, Zhang F, et al. N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery[J]. Small, 2011, 7(19):2742-2749.
[44] Huang R Y, Chiang P H, Hsiao W C, et al. Redox-sensitive polymer/SPIO nanocomplexes for efficient magnetofection and MR imaging of human cancer cells[J]. Langmuir, 2015, 31(23):6523-6531.
[45] Chen S Z, Chen S Y, Zeng Y, et al. Size-dependent SPIONs dictate IL-1β release from mouse bone marrow-derived macrophages[J]. Journal of Applied Toxicology, 2018, 38(7):978-986.